Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samer Al-Saad

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Histopathology|September 3, 2009
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinomaKhalid Al-Shibli, Samer Al-Saad, Tom Donnem, et al.
Cancer|June 16, 2010
Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancerTom Donnem, Khalid Al-Shibli, Sigve Andersen, et al.
Clinical Lung Cancer|May 10, 2011
Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor sizeTom Donnem, Sigve Andersen, Samer Al-Saad, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2008
VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cellsTom Donnem, Khalid Al-Shibli, Samer Al-Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancerKhalid I Al-Shibli, Tom Donnem, Samer Al-Saad, et al.
Plos One|May 24, 2011
Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2Sigve Andersen, Tom Donnem, Khalid Al-Shibli, et al.
Anticancer Research|May 28, 2011
Correlation and coexpression of HIFs and NOTCH markers in NSCLCSigve Andersen, Tom Donnem, Samer Al-Saad, et al.
Plos One|September 3, 2011
Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survivalSigve Andersen, Tom Donnem, Helge Stenvold, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2011
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcomeHelge Stenvold, Tom Donnem, Sigve Andersen, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2010
Diverging prognostic impacts of hypoxic markers according to NSCLC histologySigve Andersen, Marte Eilertsen, Tom Donnem, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Histopathology|September 3, 2009
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinomaKhalid Al-Shibli, Samer Al-Saad, Tom Donnem, et al.
Cancer|June 16, 2010
Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancerTom Donnem, Khalid Al-Shibli, Sigve Andersen, et al.
Clinical Lung Cancer|May 10, 2011
Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor sizeTom Donnem, Sigve Andersen, Samer Al-Saad, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2008
VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cellsTom Donnem, Khalid Al-Shibli, Samer Al-Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancerKhalid I Al-Shibli, Tom Donnem, Samer Al-Saad, et al.
Plos One|May 24, 2011
Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2Sigve Andersen, Tom Donnem, Khalid Al-Shibli, et al.
Anticancer Research|May 28, 2011
Correlation and coexpression of HIFs and NOTCH markers in NSCLCSigve Andersen, Tom Donnem, Samer Al-Saad, et al.
Plos One|September 3, 2011
Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survivalSigve Andersen, Tom Donnem, Helge Stenvold, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2011
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcomeHelge Stenvold, Tom Donnem, Sigve Andersen, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2010
Diverging prognostic impacts of hypoxic markers according to NSCLC histologySigve Andersen, Marte Eilertsen, Tom Donnem, et al.
Pageof 6